What to know about FDA approval of COVID-19 boosters for teens

The FDA authorized Pfizer’s COVID-19 booster for children 12 to 15 and reduced the wait time between the vaccine’s primary series and booster to five months.

Related Keywords

Lesbos ,Perifereia Voreiou Aigaiou ,Greece ,Karatepe ,Perifereia Kentrikis Makedonias ,Panagiotis Balaskas ,National Health Organisation ,